SCHEMBL23211159

SCHEMBL23211159

O=C(O)N1CCCC[C@]1(Cc1ccccc1)C(=O)NCc1nccnc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23211160 1.00
SCHEMBL28967583 0.92 FAAH (0.36)
SCHEMBL5717048 0.76
SCHEMBL5717115 0.75
SCHEMBL5717028 0.73
SCHEMBL4232398 0.71
SCHEMBL15878423 0.71 ALDH1A1 (0.38)
SCHEMBL16738412 0.70
SCHEMBL20958614 0.70
SCHEMBL693699 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11974999-B2 Bruton's tyrosine kinase inhibitors Liao, Xibin (US) 2024-05-07 US disclosed
US-11554118-B2 Bruton's tyrosine kinase inhibitors Liao, Xibin (US) 2023-01-17 US disclosed
US-20210121458-A1 BRUTON'S TYROSINE KINASE INHIBITORS Suzhou Baijibugong Pharmaceutical Technology Co., Ltd. (CN) 2021-04-29 US disclosed
US-20210107903-A1 BRUTON'S TYROSINE KINASE INHIBITORS Suzhou Baijibugong Pharmaceutical Technology Co., Ltd. (CN) 2021-04-15 US disclosed